Drugs & Medications
-
DOCS INFLUENCED BY BIG PHARMA
Like most businesses, pharmaceutical manufacturers lobby their customers. For a company to sell its product, it must tell its customers…
Read More » -
AGE NOT A REASON TO STOP STATINS
I’ve addressed the subject of statins in the elderly before. On March 20th of this year, I published an article…
Read More » -
DOAC’S CUT STROKE RISK IN AFIB
For at least 30 years, cardiologists have recommended patients with atrial fibrillation be placed on blood thinners, ie. anticoagulants. The…
Read More » -
CHEMOTHERAPY: HAIR LOSS IS PREVENTABLE
Cancer is a terrible disease. The symptoms of cancer range from headache, nausea, and vomiting, to jaundice, pain, and neuropathy,…
Read More » -
FOREIGN DRUGS HARDER TO GET
The cost of medical care is outrageous. Health insurance premiums, co-pays, professional fees, inpatient hospital charges, and prescription drug prices…
Read More » -
MANAGING BENIGN PROSTATE SYMPTOMS
The prostate gland is one the more common anatomic structures to cause older men problems. Usually, around age forty, sometimes…
Read More » -
EVERYONE WANTS THEIR GLP-1 TO BE THE ONE
The two big players in the GLP-1 market are the Danish pharmaceutical company Novo Nordisk, and Indiana-based Eli Lilly and…
Read More » -
SIDE EFFECTS OF STATINS
I have always downplayed the side effects of statins. In my mind, the benefits of statin drugs are so important,…
Read More » -
TIRZEPATIDE WINS!
GLP-1 medications are all you read about in the medical literature (journals, newsletters) these days. The benefits of better control…
Read More » -
THE OZEMPIC ERA
The GLP-1 Receptor Agonist with the most recognizable name is OZEMPIC. The manufacturer of semaglutide, the generic name for Ozempic,…
Read More »








